Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.
about
Clozapine versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaPrevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-AnalysisWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20)The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disordersQuality of life as patient-reported outcomes: principles of assessment.Almost all antipsychotics result in weight gain: a meta-analysis.Quality of life in schizophrenic patients.Olanzapine: a critical review of recent literature.The impact of subjective well-being under neuroleptic treatment on compliance and remission.Olanzapine: a 5-year perspective.The relationship between patient satisfaction and treatment outcomes in schizophrenia.Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design featuresComparisons between psychotropic drugs: must the risk of side effects dictate our practices?Olanzapine pamoate for the treatment of schizophrenia.Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands.Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis.Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics.Patient-oriented randomisation: A new trial design applied in the Neuroleptic Strategy Study.
P2860
Q24236422-70E08D56-12E1-4215-BF90-D5FB453AF598Q24236545-90B5A16E-1D88-43DE-9F92-FBE62BFC60F1Q26748476-577CA8D6-2334-404D-A039-A1118964EEFEQ33235110-B771D367-9351-4112-938A-98E93C0EC0D7Q33401710-924687B8-3528-4A4C-B145-B44FCE9E4B17Q33600231-C2DAD0ED-6AB4-4DC5-B07E-D3961D7A0066Q34074648-C43B1815-4E57-4C27-BC98-2C1D290C9E93Q34661499-54362F3F-9240-4C4A-901B-E1895F567FC2Q35236921-9EB457F1-6B5C-4202-BBD0-F666A7CF40CBQ36273449-B555DB48-4CE9-4171-B31C-D7B4B0903F76Q36460707-A96FF364-C3ED-43D8-95AB-719C242B6723Q36511290-EBD1DE47-9804-4934-8662-C7E1488032B2Q36626251-1F69B112-1DC5-49F5-BBDC-1F58950A5F6BQ37227479-BE82F5EE-2308-4574-9F8E-CDD27FAD449BQ37339072-EF613EF1-298F-400B-8E22-4F457E87CC2FQ37831310-26B8A240-C604-41E5-AAF0-7AE1D9B03B38Q37857856-A865EDC4-75AF-414E-85CE-7B422FA0B49DQ38068636-5B9D68B4-6AA7-4F6B-9149-6BA41AE22F51Q38649630-0E473E3F-CD26-4DF0-9B26-350B3C28CDC1Q38706468-034C531D-DBE3-438F-88CE-846A8BF8F41DQ40254338-00D1C66E-63D3-4466-8666-0E6FAD5BCE9EQ41578608-F571F82A-5E44-4E9A-89F5-126EFE4CB4A6Q48900090-889AE7A8-9D53-42FB-A7D8-FBD8058F1FB2Q50683135-30271117-0259-49DF-8B1B-AF51CE4E24F9
P2860
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Randomized double blind compar ...... n patients with schizophrenia.
@en
Randomized double blind compar ...... n patients with schizophrenia.
@nl
type
label
Randomized double blind compar ...... n patients with schizophrenia.
@en
Randomized double blind compar ...... n patients with schizophrenia.
@nl
prefLabel
Randomized double blind compar ...... n patients with schizophrenia.
@en
Randomized double blind compar ...... n patients with schizophrenia.
@nl
P2093
P2860
P1476
Randomized double blind compar ...... n patients with schizophrenia.
@en
P2093
E-U Vorbach
R W Dittmann
P2860
P304
P356
10.1111/J.1600-0447.2004.00486.X
P407
P577
2005-02-01T00:00:00Z